Mor Swiel - 23 Oct 2026 Form 4 Insider Report for Xtend AI Robotics, Inc. (XTND)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Oct 2026, 16:10:04 UTC
Prior SEC filing
19 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Aviv Shapira, as Attorney-in-Fact for Mor Swiel
Filing notes and source

Key filing fact

Mor Swiel filed Form 4 for Xtend AI Robotics, Inc. (XTND) on 27 Oct 2026.

Key facts

  • This page summarizes Mor Swiel's Form 4 filing for Xtend AI Robotics, Inc. (XTND).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Oct 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 19 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002139944 Primary reporting owner

Swiel Mor

Relationship
Chief Legal Counsel
Address
C/O XTEND AI ROBOTICS, INC., 5247 CROSSROADS PARK DRIVE, TAMPA
Signature
/s/ Aviv Shapira, as Attorney-in-Fact for Mor Swiel
Signature date
27 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XTND transaction

Common Stock

Award

Transaction value
Shares
+190,000
Change %
+30%
Price
$0.000000*
Shares after
824,484
Date
23 Oct 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XTND transaction Derivative

Performance Restricted Stock Units

Award

Transaction value
Shares
+380,000
Change %
Price
$0.000000*
Shares after
380,000
Date
23 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
380,000
Exercise price
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted under the Issuer's 2026 Equity Incentive Plan to the Reporting Person in connection with an amendment to his employment agreement with the Issuer. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Footnote F2

Represents the first of three equal tranches of 190,000 RSUs comprising a total grant of 570,000 RSUs. This first tranche is not subject to any key performance indicators and vests over a period of 36 months in 36 equal monthly installments commencing on September 3, 2026, in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

Footnote F3

Represents performance restricted stock units ("PRSUs") comprising the second and third tranches of 190,000 PRSUs each, of the total grant of 570,000 RSUs described in footnote (2), the vesting of which is conditioned upon the achievement of key performance indicators. Each PRSU represents a contingent right to receive one share of common stock of the Issuer.

Footnote F4

Each PRSU converts into one share of common stock of the Issuer upon vesting.

Footnote F5

Each of the second and third tranches vests over a period of 36 months in 36 equal monthly installments, with vesting beginning on September 3, 2026, provided that (i) the vesting of the second tranche is conditioned upon the achievement of the applicable key performance indicators on or prior to March 1, 2027, and (ii) the vesting of the third tranche is conditioned upon the achievement of the applicable key performance indicators on or prior to September 1, 2027, in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .